AstraZeneca India announces the CDSCO approval for ‘Palivizumab’, a long-awaited preventive therapy for Respiratory Syncytial Virus
New Delhi (National), 30 September 2023: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company today announced...